Co-Authors
This is a "connection" page, showing publications co-authored by Philip Davy and Bradley Willcox.
Connection Strength
2.044
-
Davy PMC, Willcox DC, Shimabukuro M, Donlon TA, Torigoe T, Suzuki M, Higa M, Masuzaki H, Sata M, Chen R, Murkofsky RL, Morris BJ, Lim E, Allsopp RC, Willcox BJ. Minimal Shortening of Leukocyte Telomere Length Across Age Groups in a Cross-Sectional Study for Carriers of a Longevity-Associated FOXO3 Allele. J Gerontol A Biol Sci Med Sci. 2018 10 08; 73(11):1448-1452.
Score: 0.688
-
Davy PMC, Allsopp RC, Donlon TA, Morris BJ, Willcox DC, Willcox BJ. FOXO3 and Exceptional Longevity: Insights From Hydra to Humans. Curr Top Dev Biol. 2018; 127:193-212.
Score: 0.652
-
Chen R, Morris BJ, Donlon TA, Masaki KH, Willcox DC, Davy PMC, Allsopp RC, Willcox BJ. FOXO3 longevity genotype mitigates the increased mortality risk in men with a cardiometabolic disease. Aging (Albany NY). 2020 12 01; 12(23):23509-23524.
Score: 0.200
-
Donlon TA, Davy PMC, Willcox BJ. Correction to: Analysis of FOXO3 Gene Polymorphisms Associated with Human Longevity. Methods Mol Biol. 2019; 1890:C1.
Score: 0.175
-
Donlon TA, Davy PMC, Willcox BJ. Analysis of FOXO3 Gene Polymorphisms Associated with Human Longevity. Methods Mol Biol. 2019; 1890:251-258.
Score: 0.175
-
Willcox BJ, Morris BJ, Tranah GJ, Chen R, Masaki KH, He Q, Willcox DC, Allsopp RC, Moisyadi S, Gerschenson M, Davy PMC, Poon LW, Rodriguez B, Newman AB, Harris TB, Cummings SR, Liu Y, Parimi N, Evans DS, Donlon TA. Longevity-Associated FOXO3 Genotype and its Impact on Coronary Artery Disease Mortality in Japanese, Whites, and Blacks: A Prospective Study of Three American Populations. J Gerontol A Biol Sci Med Sci. 2017 May 01; 72(5):724-728.
Score: 0.156